课题基金 / 基金详情

NSABP BREAST CANCER PREVENTION TRIAL

NSABP BREAST CANCER PREVENTION TRIAL
NSABP 乳腺癌预防试验
批准号:
6274604
负责人:
LAURENCE HOWARD BAKER
金额:
$2.15万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

LAURENCE HOWARD BAKER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Previous studies suggested that the estrogen antagonist Tamoxifen may reduce the incidence of second primary breast cancers in women receiving this medication as adjuvant therapy for early stage breast cancer. The Breast Cancer Prevention Trial (BCPT) is a multi-center trial designed to determine whether administration of Tamoxifen to women at increased risk of developing breast cancer will decrease the incidence of and mortality due to breast cancer in this population. The University of Michigan was selected as one of the centers participating in this trial.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core A: Administrative Core
Developmental Research Program
Integrated Translational Cancer Science Center
  • 批准号:
    8606928
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2014
  • 负责人:
    LAURENCE HOWARD BAKER
  • 依托单位:
Integrated Translational Cancer Science Center
  • 批准号:
    8868958
  • 项目类别:
  • 资助金额:
    $40.49万
  • 财政年份:
    2014
  • 负责人:
    LAURENCE HOWARD BAKER
  • 依托单位:
海外基金